This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Events OverviewITM Symposium on Actinium-225 Targeted Radionuclide Therapy at Theranostics World CongressITM Precision Oncology Symposium 2022ITM's Symposium at NuklearMedizin 20222nd ICPO Forum for Theranostics in Precision OncologyITM's ESMO 2021 Industry Satellite SymposiumITM Precision Oncology Symposium 2021COMPETE e-poster at AACR 2021

ITM Symposium on Actinium-225 Targeted Radionuclide Therapy at Theranostics World Congress

Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks

 

The symposium titled, “Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” will take place on June 25, from 11:30 am to 12:55 pm CET. Participants can attend in person or join via live stream, which will be available on the TWC website ahead of the congress.

The event will feature expert speakers, Prof. Matthias Eiber, Associate Professor, Clinic and Polyclinic for Nuclear Medicine, Klinikum rechts der Isar, TU Munich, Prof. Katharina Lückerath, Preclinical Theranostics, Clinic for Nuclear Medicine, University Hospital Essen and Neil Quigley, Global Product Manager at ITM.

 

Programm 6th Theranostics World Congress

TWC Official Website

 

Symposium Program & Speakers

 

An Evaluation of Current and Prospective 225Ac Production Methods
Neil Quigley, Global Product Manager, ITM, Garching / Munich


225Ac-PSMA for the Treatment of Prostate Cancer – Preclinical Experience
Prof. Katharina Lückerath, University Hospital Essen


Current Clinical Experience for 225Ac-PSMA in mCRPC
Prof. Matthias Eiber, Klinikum rechts der Isar, Technical University of Munich